MedPath

Comparison of PD and bile duct resection for middle bile duct cancer (Is additional-PD after bile duct segmental resection sufficient to surgical treatment for middle bile duct cancer?) Japan-Korea Collaborative Research of Hepato-Biliary-Pancreatic Surgery Biliary part

Not Applicable
Recruiting
Conditions
Middle bile duct cancer
Registration Number
JPRN-UMIN000017914
Lead Sponsor
Japanese Ssociety of Hepato-Biliary-Pancreatic Surgery
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
3600
Inclusion Criteria

Not provided

Exclusion Criteria

-Bismuth type I hilar cholangiocarcinoma -cT4 cancer (With invasion to liver parenchyma by preoperative diagnostic imaging and intraoperative macroscopic findings) (cT1/2/3 but pT4 cancer should not be excluded) -M1 desease -Preoperative chemotherapy and/or radiation -With hepatectomy (additional hepatectomy after BDSR or PD is excluded in this study) -Patient with other cancer within 5-year

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
desease free survival
Secondary Outcome Measures
NameTimeMethod
Overall survival R0 resection rate Morbidity rate Mortality rate Recurrence rate Site of Recurrence
© Copyright 2025. All Rights Reserved by MedPath